AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Healthcare Contracts Are Being Rewritten for AI, Privacy, and IP Risk
Nixon Peabody says healthcare technology contracts are moving beyond boilerplate as AI introduces new questions about privacy, intellectual property, and liability. The legal work now determines whether AI deployments can scale responsibly or get stuck in endless negotiation.
How drug discovery will fight over who gets credit for AI contributions
Bloomberg Law examines a fast-emerging legal and commercial question: how to assign credit when AI contributes to drug discovery. As AI becomes more embedded in discovery pipelines, questions about inventorship, attribution, and value-sharing are moving from theory to contract terms.
Law360 Highlights the Contracting Stakes Behind Lilly’s New AI Discovery Pact
Law360’s take on Lilly’s $2.75 billion Insilico agreement is significant because it surfaces the legal and deal-structure dimensions of AI drug discovery. As more pharma-AI collaborations turn into high-value licensing arrangements, intellectual property, milestone design, and control over generated assets are becoming core strategic issues.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.